Form 4: Bayview Legacy Sells 40,000 Arteris Shares
Insider Transaction Report
Bayview Legacy, LLC, a 10% owner of Arteris, Inc., sold 40,000 shares of common stock over two days in late March 2026 under a pre-arranged 10b5-1 trading plan.
Summary
- Bayview Legacy, LLC, a 10% owner and entity associated with a director of Arteris, Inc. (AIP), sold a total of 40,000 shares of common stock.
- The sales occurred on March 25, 2026, and March 26, 2026.
- On March 25, 2026, 7,012 shares were sold at a weighted average price of $18.0309 per share, with prices ranging from $18.00 to $18.08.
- On March 26, 2026, 32,988 shares were sold at a weighted average price of $18.3458 per share, with prices ranging from $18.00 to $18.70.
- These transactions were executed pursuant to a Rule 10b5-1 trading plan adopted by K. Charles Janac, manager of Bayview Legacy, LLC, on March 5, 2025.
- Following these transactions, Bayview Legacy, LLC indirectly beneficially owns 9,189,071 shares of Arteris, Inc. common stock.
- K. Charles Janac, who controls Bayview Legacy, LLC, also filed a separate Form 4 for these same transactions.
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a moderately negative signal due to the significant insider selling, despite it being pre-planned. While 10b5-1 plans mitigate concerns of opportunistic timing, the reduction in insider ownership is generally not a bullish indicator.
Positives
- The sales were conducted under a pre-arranged 10b5-1 trading plan, indicating a planned divestment rather than an immediate reaction to new, undisclosed information.
Negatives
- A significant insider (10% owner and director-affiliated entity) sold 40,000 shares of common stock, reducing their overall stake in the company.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that insider sales, even when pre-planned via a 10b5-1 plan, can sometimes be interpreted by the market as a signal regarding management's long-term view of the company's valuation, especially from a significant owner like Bayview Legacy, LLC.
Stakeholder Impact
- Shareholders may view the insider selling as a potential lack of confidence from a significant owner, which could influence investment decisions.
Key Dates
| Date | Description |
|---|---|
| 03/05/2025 | Date K. Charles Janac, as manager of Bayview Legacy, LLC, adopted the 10b5-1 trading plan. |
| 03/25/2026 | Transaction date for the sale of 7,012 shares of common stock by Bayview Legacy, LLC. |
| 03/26/2026 | Transaction date for the sale of 32,988 shares of common stock by Bayview Legacy, LLC. |
| 03/27/2026 | Date the Form 4 was signed by K. Charles Janac. |
Recommendation
holdWhile the insider selling by Bayview Legacy, LLC, a 10% owner, is a negative signal, it was executed under a pre-arranged 10b5-1 plan, which suggests it was not based on new, undisclosed negative information. Given the planned nature, it warrants a 'hold' rather than a 'sell' unless further negative catalysts emerge or the selling intensifies. Investors should monitor future insider activity and company performance.
Keywords
Arteris Inc., AIP, Bayview Legacy LLC, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, K. Charles Janac, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.